作者: Lewis H. Mervin , Simon Johansson , Elizaveta Semenova , Kathryn A. Giblin , Ola Engkvist
DOI: 10.1016/J.DRUDIS.2020.11.027
关键词:
摘要: Machine learning and artificial intelligence are increasingly being applied to the drug-design process as a result of the development of novel algorithms, growing access, the falling cost …